Assembly Biosciences is advancing a new class of oral therapeutics for the treatment of hepatitis B (HBV) infection and novel oral live biotherapeutics for disorders associated with the microbiome.
Copyright West LLC. Minimum 15 minutes delayed.
Feb 26, 2020 at 2:00 PM EST
Nov 11, 2019 at 8:30 AM EST
Jun 22, 2019